For which patients is Lenvatinib used?

Lenvatinib is used for patients with:

Thyroid cancer: It is indicated for the treatment of locally recurrent or metastatic differentiated thyroid carcinoma that is refractory to radioactive iodine therapy.

Hepatocellular carcinoma (HCC): Lenvatinib is used for patients with unresectable HCC who have not received prior systemic therapy.

Renal cell carcinoma (RCC): It can be used in combination with everolimus for patients with advanced renal cell carcinoma who have received prior anti-angiogenic therapy.

Endometrial carcinoma: Lenvatinib is also indicated in combination with pembrolizumab for patients with advanced endometrial carcinoma who have progressed following prior treatment.Know more about Lenvatinib Price Malaysia

Lenvatinib works as a multi-kinase inhibitor, targeting various receptors involved in tumor growth and angiogenesis. Treatment decisions should always be made in consultation with a healthcare provider based on the individual patient's condition and overall health.

What is the indication for Lenvatinib acetate?

Lenvatinib acetate is indicated for the treatment of:

Differentiated thyroid cancer: For patients with locally recurrent or metastatic disease that is refractory to radioactive iodine therapy.

Hepatocellular carcinoma (HCC): For patients with unresectable HCC who have not received prior systemic therapy.

Renal cell carcinoma (RCC): In combination with everolimus for patients with advanced renal cell carcinoma who have received prior anti-angiogenic therapy.

Endometrial carcinoma: In combination with pembrolizumab for patients with advanced endometrial carcinoma that has progressed following prior treatment.

Lenvatinib acts as a multi-kinase inhibitor, targeting various pathways involved in tumor growth and angiogenesis. Always consult a healthcare provider for specific treatment recommendations based on individual circumstances.

What are the cautions of Lenvatinib?

Lenvatinib has several cautions to consider:

Hypertension: Lenvatinib can cause significant increases in blood pressure, so regular monitoring is essential.

Hepatotoxicity: Liver function tests should be monitored, as lenvatinib can lead to liver enzyme elevations and liver dysfunction.

Thyroid function: Patients may experience hypothyroidism; thyroid function tests should be monitored regularly.

Gastrointestinal perforations: There is a risk of gastrointestinal perforations, which can be serious.

Wound healing: Lenvatinib may impair wound healing, so caution is advised in patients undergoing surgery.

Proteinuria: Patients should be monitored for proteinuria, as it can occur with lenvatinib treatment.

QT interval prolongation: Caution is needed in patients with a history of QT prolongation or those on medications that affect the QT interval.

Pregnancy and breastfeeding: Lenvatinib is contraindicated during pregnancy and breastfeeding due to potential harm to the fetus or infant.

Drug interactions: Lenvatinib can interact with various medications, especially those affecting liver enzymes, necessitating a comprehensive review of the patient’s medications.

Patients should discuss these cautions with their healthcare provider to ensure safe and effective use of lenvima 4mg price.

Naijamatta is a social networking site,

download Naijamatta from Google play store or visit www.naijamatta.com to register. You can post, comment, do voice and video call, join and open group, go live etc. Join Naijamatta family, the Green app.